Six International Organisations Pledge Collaboration On Local Production Of Medicines 24/05/2019 Catherine Saez While delegates remained bogged down today in negotiations to find consensus on a resolution to increase transparency of pharma prices, five United Nations agencies and the Global Fund to Fight AIDS, Tuberculosis and Malaria forged a brand new collaboration to promote local production of medicines. The World Health Organization, the UN Industrial Development Organization (UNIDO), […] Continue reading -> Following 110 years of neglect, an official day for Chagas disease is declared 24/05/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 24 May 2019 The delegates at the World Health Assembly (WHA) have today approved the creation of a World Chagas Day. People affected by Chagas worldwide celebrate this important step in fighting for recognition of this neglected disease. Image Credits: DNDi. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Following 110 years of neglect, an official day for Chagas disease is declared 24/05/2019 Editorial team [DNDi Press Release] Geneva, Switzerland – 24 May 2019 The delegates at the World Health Assembly (WHA) have today approved the creation of a World Chagas Day. People affected by Chagas worldwide celebrate this important step in fighting for recognition of this neglected disease. Image Credits: DNDi. Continue reading -> Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Little Progress Over Price Transparency Resolution; Negotiators Behind Closed Doors 24/05/2019 Catherine Saez Secrecy was the watchword Friday as countries huddled together behind closed doors trying to reach agreement on a WHA resolution that would shed more sunshine on the real prices of medicines in national and global pharmaceutical markets. Image Credits: Max Pixel, Catherine Saez. Continue reading -> Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Price Transparency In Medicines Markets – Scrutinizing Evidence Behind The Claims 24/05/2019 Editorial team As the debate over a draft resolution supporting greater price transparency for medicines in national and global markets intensifies, with closed-door consultations among countries at the 72nd World Health Assembly continuing late into the night, Health Policy Watch continues to feature diverse “Inside Views” on this charged issue. Here, Suerie Moon, MPA PhD, faculty member […] Continue reading -> Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Behind The Headlines: How Can Industry Contribute To Cancer Care As Part Of Universal Health Coverage? 24/05/2019 Elaine Ruth Fletcher From preventive screening to the quality of nursing care and the structure of national insurance systems, patients face multiple barriers to cancer prevention, treatment and care, said a high-level panel of experts at a side event on the margins of this week’s World Health Assembly (20-28 May). Image Credits: UnternehmerTUM/@birdyfoto.de. Continue reading -> Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Future Of Drug Pricing Resolution Hangs In Balance At World Health Assembly 23/05/2019 Catherine Saez The fate of a potentially game-changing World Health Assembly resolution that would support greater national and global transparency in drug pricing remained in the balance today as the country co-sponsors tabled a resolution riddled with comments and caveats, and a “drafting group” was urgently formed to huddle on ways to move forward on a compromise […] Continue reading -> How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
How transparency of the costs of clinical trials will improve policy making 23/05/2019 Editorial team [Re-posted from Knowledge Ecology International.] By James Love, Director of Knowledge Ecology International (KEI) – 22 May 2019 Perhaps the toughest issue in the 72nd World Health Assembly negotiations on a WHO transparency resolution concerns the proposal to require public reporting of the costs of each clinical trial undertaken for development of drugs, vaccines, cell- […] Continue reading -> Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Ebola Epidemic Enduring, Conflict Zones Complicate Response, Need Of Breaking Silos Between Actors 21/05/2019 Catherine Saez The ongoing Ebola outbreak in the Democratic Republic of the Congo (DRC) is not related to the lack of means or experience to fight the epidemic, but the difficulty to reach communities, the World Health Organization Director-General told the World Health Assembly today. The DRC Minister of Health illustrated the complexity of the response, linked […] Continue reading -> Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Collaboration & Science To Fight Epidemics, A Long Road Still Ahead – Speakers Say On the Margins Of WHA 21/05/2019 Catherine Saez The Ebola epidemic in the Democratic Republic of the Congo is enduring despite efforts deployed and progress achieved, mainly because of the difficulty to reach communities. The complexity of the response to this epidemic prompts actors to rethink their strategy, as explained by the head of Wellcome Trust yesterday on the side of the World […] Continue reading -> Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts
Fight The Fakes Panel Spotlights Digital Innovation To Combat Dangerous Fake Drugs 21/05/2019 Divya Schlesinger Raised in the digital era and fluent in the innovations of technology, youth are the driving force behind many advancements in global health, even spearheading a campaign against falsified and substandard medicines. Fight the Fakes, a campaign to raise public awareness about the dangers of falsified medicines, joined forces with the 72nd World Health Assembly […] Continue reading -> Posts navigation Older postsNewer posts